Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_assertion type Assertion NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_head.
- NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_assertion description "[Intriguingly, all these normalization strategies indicated that circulating miRNA-155 is greatly upregulated in patients with HCC and GC, but downregulated in benign hepatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_provenance.
- NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_assertion evidence source_evidence_literature NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_provenance.
- NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_assertion SIO_000772 25719241 NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_provenance.
- NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_assertion wasDerivedFrom befree-2016 NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_provenance.
- NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_assertion wasGeneratedBy ECO_0000203 NP1266411.RAFifZ7CfjkfBg9j-CvdVyRbdFpF2gwm1y48bPO7GDGYg130_provenance.